Información*
| Nombre | MARTHA CECILIA ROSALES HERNANDEZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | QUÍMICA FARMACÉUTICA |
| Especialidad | NUEVAS MOLECULAS |
| CVU | 103667 |
| Institución | |
|---|---|
| Dependencia | UNIDADES ACADEMICAS DE NIVEL SUPERIOR |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 3 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- Increase in BACE1 Phosphorylation in the Rat Hippocampus and Phytosphingosine in Plasma After Chronic Administration of Scopolamine International Journal of Molecular Sciences
- 2025
- Monothiooxalamide–Benzothiazole Hybrids: Predictive Docking on HDAC6, Synthesis, Molecular Structure, and Antiproliferative Activity on Breast Cancer Cells International Journal of Molecular Sciences
- Condensation Reactions of 2-Aminothiophenoles to Afford 2-Substituted Benzothiazoles of Biological Interest: A Review (2020–2024) International Journal of Molecular Sciences
- 2024
- Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer’s Disease Molecules
- 2023
- Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines International Journal of Molecular Sciences
- Design, Synthesis and Biological Activities of (Thio)Urea Benzothiazole Derivatives International Journal of Molecular Sciences
- 2022
- In Silico and In Vitro Studies of Benzothiazole-Isothioureas Derivatives as a Multitarget Compound for Alzheimer’s Disease International Journal of Molecular Sciences
- LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells International Journal of Molecular Sciences
- Synthesis and Biological Importance of 2-(thio)ureabenzothiazoles Molecules
- Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6 Pharmaceuticals